Warning! GuruFocus detected
2 Severe warning signs
with EGP.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Egalet Corp
NAICS : 325411
SIC : 2833
ISIN : US28226B1044
Compare
Compare
Traded in other countries / regions
Description
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.11 | |||||
| Debt-to-Equity | 4.18 | |||||
| Debt-to-EBITDA | -3.93 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.82 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 52.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 54.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.65 | |||||
| Quick Ratio | 0.54 | |||||
| Days Inventory | 173.91 | |||||
| Days Sales Outstanding | 178.58 | |||||
| Days Payable | 301.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.88 | |||||
| Operating Margin % | -38.4 | |||||
| Net Margin % | -75.88 | |||||
| FCF Margin % | -186.72 | |||||
| ROE % | -96.47 | |||||
| ROA % | -20.08 | |||||
| ROIC % | -10.51 | |||||
| ROC (Joel Greenblatt) % | -637.61 | |||||
| ROCE % | -22.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.01 | |||||
| PB Ratio | 0.02 | |||||
| Price-to-Operating-Cash-Flow | 0.09 | |||||
| EV-to-EBIT | -2.41 | |||||
| EV-to-EBITDA | -3.39 | |||||
| EV-to-Revenue | 1.4 | |||||
| Earnings Yield (Greenblatt) % | -41.49 | |||||
| FCF Yield % | 1364.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Egalet Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 25.03 | ||
| EPS (TTM) (€) | -0.97 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 549.23 | ||
| 14-Day RSI | 54.28 | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 0.01 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0 - 0.73 | ||
| Shares Outstanding (Mil) | 56.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Egalet Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Egalet Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Egalet Corp Frequently Asked Questions
What is Egalet Corp(STU:EGP)'s stock price today?
The current price of STU:EGP is €0.00. The 52 week high of STU:EGP is €0.73 and 52 week low is €0.00.
When is next earnings date of Egalet Corp(STU:EGP)?
The next earnings date of Egalet Corp(STU:EGP) is .
Does Egalet Corp(STU:EGP) pay dividends? If so, how much?
Egalet Corp(STU:EGP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers